Cancer Screening in China: The 530 Million Person Gap
China accounts for roughly one-quarter of the world's new cancer cases each year. Approximately 4.8 million people are diagnosed annually, and about 2.6 million die from it. But the most striking difference between China and the US isn't how many people get cancer. It's when they find out.
The scale of the gap
A 2023 analysis in The Lancet Public Health found that China has approximately 534 million adults aged 45-74 eligible for screening for the five deadliest cancers: lung, liver, stomach, colorectal, and esophageal. Organized screening reaches about 0.5 million people per year. Coverage: less than 1%.
The one bright spot is cervical cancer screening, which reached 51.5% of women aged 35-64 in 2023-2024, meeting the government's target of 50% by 2025. But for the cancers that kill the most Chinese adults, population-level screening barely exists.
What that looks like
Source: The Lancet Public Health, 2021
A multicenter study in The Lancet Public Health (2021) found that 52.8% of Chinese cancer patients across five common cancers were diagnosed at Stage III or IV. For men, that number was 64.1%, largely because the cancers that disproportionately affect men (lung, liver, stomach) have almost no screening infrastructure. Liver cancer, which is far more common in China due to higher hepatitis B rates, showed a 56.9% late-stage diagnosis rate, comparable to US rates for the same cancer.
The result: China's overall 5-year cancer survival rate is 43.7%, compared to 69.2% in the US. That gap is driven primarily by late detection, not differences in treatment quality.
The barrier is awareness
Among high-risk Chinese adults who declined colorectal screening, 71.1% said they had no symptoms and didn't think they needed it. The same information gap exists in the US, but at a much larger scale.
What's changing
The Chinese government's Healthy China 2030 initiative has set explicit screening expansion targets. The Cancer Prevention and Control Implementation Plan (2023-2030) focuses on organized screenings in high-risk areas, and the National Cancer Center has proposed models where the government subsidizes initial screening costs for high-risk individuals.
But scaling from 0.5 million to 534 million is a generational challenge. With over 1 billion smartphone users and health services already integrated into platforms like WeChat and Alipay, digital tools that help individuals understand their own risk are a critical bridge while infrastructure catches up.
fixyou.app gives you a personalized cancer screening plan in under 2 minutes. Free, in both English and Chinese (中文). Whether you're in the US or China, knowing what screenings apply to you is the first step.